Guardant Health Business Segments — Cost of revenue increased by 11.8% to $101.56M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 40.7%, from $72.19M to $101.56M. This increase may warrant attention — for this metric, lower values are generally preferred.
A decrease relative to revenue indicates improved operational efficiency and better margins, while an increase may suggest rising production costs or supply chain inefficiencies.
This metric captures the direct costs associated with producing and delivering the diagnostic tests and services sold by...
Commonly referred to as Cost of Goods Sold (COGS) in manufacturing and diagnostic service industries.
gh_segment_reportable_segment_cost_of_revenue| Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|
| Value | $63.17M | $70.40M | $70.42M | $72.19M | $78.30M | $90.87M | $101.56M |
| QoQ Change | — | +11.4% | +0.0% | +2.5% | +8.5% | +16.1% | +11.8% |
| YoY Change | — | — | — | +14.3% | +11.2% | +29.0% | +40.7% |